However, putative underlying mechanisms linking NAFLD/NASH to the development and progression of cardiovascular disease may include visceral adipose tissue expansion, insulin resistance/hyperinsulinemia, endothelial dysfunction, chronic inflammation, hypercoagulability, and impaired IGF-1 production [9]–[16]. The gene discussed is IGF1; the disease is endothelial dysfunction.